Merete Bjørnslett

870 total citations
20 papers, 530 citations indexed

About

Merete Bjørnslett is a scholar working on Oncology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Merete Bjørnslett has authored 20 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 8 papers in Molecular Biology. Recurrent topics in Merete Bjørnslett's work include Genetic factors in colorectal cancer (8 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer-related Molecular Pathways (5 papers). Merete Bjørnslett is often cited by papers focused on Genetic factors in colorectal cancer (8 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer-related Molecular Pathways (5 papers). Merete Bjørnslett collaborates with scholars based in Norway, Finland and Portugal. Merete Bjørnslett's co-authors include Ragnhild A. Lothe, Stine A. Danielsen, Guro E. Lind, Jarle Bruun, Anita Sveen, Peter W. Eide, Kaja C. G. Berg, Ina A. Eilertsen, Leonardo A. Meza‐Zepeda and Mette Eknæs and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Merete Bjørnslett

20 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Merete Bjørnslett Norway 11 292 238 121 118 66 20 530
Emily J. Greenspan United States 14 273 0.9× 225 0.9× 141 1.2× 160 1.4× 69 1.0× 22 626
Kaja C. G. Berg Norway 11 302 1.0× 331 1.4× 206 1.7× 176 1.5× 85 1.3× 19 671
Jennifer M. Shipman United States 11 378 1.3× 128 0.5× 123 1.0× 120 1.0× 51 0.8× 13 539
Carla Azzurra Amoreo Italy 15 249 0.9× 193 0.8× 148 1.2× 61 0.5× 75 1.1× 25 492
Prabhjot S. Mundi United States 9 290 1.0× 175 0.7× 92 0.8× 87 0.7× 111 1.7× 27 490
Vera Timmermans‐Wielenga Denmark 16 286 1.0× 221 0.9× 195 1.6× 59 0.5× 62 0.9× 21 624
Ma Xiaoling United States 3 586 2.0× 159 0.7× 101 0.8× 140 1.2× 61 0.9× 4 698
Jingshu Geng China 19 484 1.7× 317 1.3× 167 1.4× 261 2.2× 79 1.2× 36 777
Denis Alférez United Kingdom 12 340 1.2× 300 1.3× 127 1.0× 41 0.3× 86 1.3× 17 551
Tom Januario United States 5 463 1.6× 262 1.1× 126 1.0× 59 0.5× 95 1.4× 8 628

Countries citing papers authored by Merete Bjørnslett

Since Specialization
Citations

This map shows the geographic impact of Merete Bjørnslett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merete Bjørnslett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merete Bjørnslett more than expected).

Fields of papers citing papers by Merete Bjørnslett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merete Bjørnslett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merete Bjørnslett. The network helps show where Merete Bjørnslett may publish in the future.

Co-authorship network of co-authors of Merete Bjørnslett

This figure shows the co-authorship network connecting the top 25 collaborators of Merete Bjørnslett. A scholar is included among the top collaborators of Merete Bjørnslett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merete Bjørnslett. Merete Bjørnslett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sveen, Anita, Bjarne Johannessen, Sigrid Marie Kraggerud, et al.. (2024). Evolutionary mode and timing of dissemination of high-grade serous carcinomas. JCI Insight. 9(3). 1 indexed citations
2.
Gansmo, Liv B., Merete Bjørnslett, Pål Romundstad, et al.. (2021). Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer. Scientific Reports. 11(1). 23463–23463. 7 indexed citations
3.
Bruun, Jarle, Peter W. Eide, Christian H. Bergsland, et al.. (2021). E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models. Molecular Oncology. 16(12). 2312–2329. 9 indexed citations
4.
Helwa, Reham, Liv B. Gansmo, Merete Bjørnslett, et al.. (2021). Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer. Biomarkers. 26(4). 302–308. 4 indexed citations
5.
Bergsland, Christian H., Jarle Bruun, Marianne G. Guren, et al.. (2020). Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer. ESMO Open. 5(6). e001040–e001040. 6 indexed citations
6.
Lopes, Nair, Christian H. Bergsland, Jarle Bruun, et al.. (2020). A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis. Gastric Cancer. 23(5). 811–823. 22 indexed citations
7.
Berg, Kaja C. G., Anita Sveen, Sharmini Alagaratnam, et al.. (2020). Genomic and prognostic heterogeneity among RAS/BRAFV600E/TP53 co‐mutated resectable colorectal liver metastases. Molecular Oncology. 15(4). 830–845. 11 indexed citations
8.
Lopes, Nair, Christian H. Bergsland, Merete Bjørnslett, et al.. (2019). Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2. Laboratory Investigation. 100(1). 120–134. 21 indexed citations
9.
Gansmo, Liv B., Merete Bjørnslett, Mari K. Halle, et al.. (2017). MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk. BMC Cancer. 17(1). 97–97. 18 indexed citations
10.
Berg, Kaja C. G., Peter W. Eide, Ina A. Eilertsen, et al.. (2017). Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Molecular Cancer. 16(1). 116–116. 284 indexed citations
11.
Landskron, Johannes, Sigrid Marie Kraggerud, Elisabeth Wik, et al.. (2017). C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease. PLoS ONE. 12(7). e0182030–e0182030. 15 indexed citations
12.
Gansmo, Liv B., Merete Bjørnslett, Mari K. Halle, et al.. (2016). The MDM4 SNP34091 (rs4245739) C-allele is associated with increased risk of ovarian—but not endometrial cancer. Tumor Biology. 37(8). 10697–10702. 22 indexed citations
13.
Bjørnslett, Merete, Alv A. Dahl, Øystein Sørebø, & Anne Dørum. (2015). Psychological distress related to BRCA testing in ovarian cancer patients. Familial Cancer. 14(4). 495–504. 21 indexed citations
14.
Bjørnslett, Merete, Stian Knappskog, Per Eystein Lønning, & Anne Dørum. (2012). Effect of the MDM2 promoter polymorphisms SNP309T>G and SNP285G>C on the risk of ovarian cancer in BRCA1 mutation carriers. BMC Cancer. 12(1). 454–454. 10 indexed citations
15.
Knappskog, Stian, Liv B. Gansmo, Pål Romundstad, et al.. (2012). MDM2 Promoter SNP344T>A (rs1196333) Status Does Not Affect Cancer Risk. PLoS ONE. 7(4). e36263–e36263. 10 indexed citations
16.
Bjørnslett, Merete, Stian Knappskog, Per Eystein Lønning, & Anne Dørum. (2011). Associations between MDM2 SNP309 and SNP285C haplotypes and ovarian cancer risk in BRCA1 mutation carriers.. Journal of Clinical Oncology. 29(15_suppl). 5030–5030. 1 indexed citations
17.
Danielsen, Stine A., Guro E. Lind, Merete Bjørnslett, et al.. (2009). Novel mutations of the suppressor genePTENin colorectal carcinomas stratified by microsatellite instability- andTP53mutation- status. Human Mutation. 30(6). 1023–1023. 14 indexed citations
18.
Danielsen, Stine A., Guro E. Lind, Merete Bjørnslett, et al.. (2008). Novel mutations of the suppressor genePTENin colorectal carcinomas stratified by microsatellite instability- andTP53mutation- status. Human Mutation. 29(11). E252–E262. 34 indexed citations
19.
Rustad, Cecilie F., Merete Bjørnslett, Ketil Heimdal, et al.. (2006). Germline PTEN mutations are rare and highly penetrant. Hereditary Cancer in Clinical Practice. 4(4). 177–177. 12 indexed citations
20.
Aamot, Hege Vangstein, Merete Bjørnslett, Jan Delabie, & Sverre Heim. (2005). t(14;22)(q32;q11) in non‐Hodgkin lymphoma and myeloid leukaemia: molecular cytogenetic investigations. British Journal of Haematology. 130(6). 845–851. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emily J. Greenspan Breakdown of academic impact, for papers by Kaja C. G. Berg Breakdown of academic impact, for papers by Jennifer M. Shipman Breakdown of academic impact, for papers by Carla Azzurra Amoreo Breakdown of academic impact, for papers by Prabhjot S. Mundi Breakdown of academic impact, for papers by Vera Timmermans‐Wielenga Breakdown of academic impact, for papers by Ma Xiaoling Breakdown of academic impact, for papers by Jingshu Geng Breakdown of academic impact, for papers by Denis Alférez Breakdown of academic impact, for papers by Tom Januario
Rankless by CCL
2026